News | June 12, 2014

Peer-Reviewed Article Puts Focus on Infections From Conventional Endoscopes

June 12, 2014 — A recent peer-reviewed article published earlier this year in the British Medical Journal (BMJ) by Steve Brozak and Anne Marie Noronha again establishes a case for an alternative to the conventional endoscope cleaning process and reviews why conventional cleaning puts patients at risk of infection. The publication, "A 21st century nosocomial issue with endoscopes," also identifies the sterile, disposable EndoSheath technology from Vision-Sciences as a safe, cost-effective alternative to conventional flexible endoscopes.

Key points stated in the BMJ article include:

  • Reprocessing conventional flexible endoscopes is "time-consuming, labor-intensive, expensive and, most importantly, susceptible to failure."
  • Due to "limited surveillance, limited reporting, and lack of immediate clinical symptoms of patients," experts agree that cross-contamination is significantly under-reported.
  • Infections "resulting from scope contamination breaks the trust between patients and doctors and places a financial burden on healthcare institutions."
  • Research shows that using EndoSheath technology and its simplified cleaning and disinfection procedure offers "a vast improvement over current decontamination procedures."
  • EndoSheath technology eliminates "unreliable and cumbersome reprocessing" of conventional endoscopes by condensing the protocol into just a few steps, and "reduces reprocessing time by up to 31 minutes."
  • Due to its design, the technology is "more cost effective, reduces repair costs, and decreases investment in multiple scopes that are out of operation while being cleaned."


The flexible EndoSheath technology is patented and cleared by the U.S. Food and Drug Administration (FDA).

For more information: http://www.wbbsec.com/wp-content/uploads/2014/03/BMJ-endoscope-infection...

Related Content

Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
SBRT Considered Safe Treatment Option for Patients With Multiple Metastases
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (SBRT) could be used...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...
Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer. ASTRO 2018 #ASTRO2018 #ASTRO #ASTRO18

Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer.

News | Radiation Oncology | October 30, 2018
October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to